R I Levy, J Morganroth, B M Rifkind. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Blood Proteins/analysisCholesterol/bloodCholestyramine Resin/therapeutic useChylomicrons/bloodClofibrate/therapeutic useCosts and Cost AnalysisDiet TherapyDrug Therapy, CombinationHumansHyperlipidemias/bloodHyperlipidemias/classificationHyperlipidemias/drug therapyHyperlipidemias/metabolismHyperlipidemias/therapyHypolipidemic Agents/therapeutic useLipoproteins/bloodLipoproteins/metabolismLipoproteins, HDL/bloodLipoproteins, LDL/bloodLipoproteins, VLDL/bloodNeomycin/therapeutic useNicotinic Acids/therapeutic usePhospholipids/bloodSitosterols/therapeutic useThyroxine/therapeutic useTriglycerides/blood
Substances: See more » Blood ProteinsChylomicronsHypolipidemic AgentsLipoproteinsLipoproteins, HDLLipoproteins, LDLLipoproteins, VLDLNicotinic AcidsPhospholipidsSitosterolsTriglyceridesCholestyramine ResinCholesterolClofibrateNeomycinThyroxine
Year: 1974 PMID: 4363888 DOI: 10.1056/NEJM197406062902306
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245